Author Archives for Adeline Chauvigné

Lemer Pax: Posijet®, the history of an exemplary partnership

The latest version of Posijet®, a mobile unit for the preparation and injection of high-energy radiopharmaceuticals, has become the compact... View Article

Rédigé par Adeline Chauvigné, le 2017-06-07

Lemer Pax: Posijet®, the history of an exemplary partnership

The latest version of Posijet®, a mobile unit for the preparation and injection of high-energy radiopharmaceuticals, has become the compact... View Article

OSE Immunotherapeutics: last news

OSE Immunotherapeutics present significant data on Selective Anti-SIRPa OSE-172 (Effi-DEM) OSE Immunotherapeutics announced that the Company presented in oral session significant data on... View Article

Portrait Olivier KITTEN, Affilogic

  Olivier KITTEN, Founder & CEO Affilogic   Atlanpole: What is the pitch of your business? Olivier Kitten: Affilogic is a... View Article

Rédigé par Adeline Chauvigné, le 2017-05-17

Portrait Olivier KITTEN, Affilogic

  Olivier KITTEN, Founder & CEO Affilogic   Atlanpole: What is the pitch of your business? Olivier Kitten: Affilogic is a... View Article

2017 BIO International Convention in San Diego

The 2017 Bio US will be held from June 19 to 22 in San Diego (USA). Atlanpole Biotherapies is preparing... View Article

Rédigé par Adeline Chauvigné, le 2017-05-17

2017 BIO International Convention in San Diego

The 2017 Bio US will be held from June 19 to 22 in San Diego (USA). Atlanpole Biotherapies is preparing... View Article

Valneva Reports Best Financial Results in the Company’s History

Valneva Reports Best Financial Results in the Company’s History with its First Year of Positive EBITDA in 2016 The Company... View Article

Rédigé par Adeline Chauvigné, le 2017-05-10

Valneva Reports Best Financial Results in the Company’s History

Valneva Reports Best Financial Results in the Company’s History with its First Year of Positive EBITDA in 2016 The Company... View Article

Ose Immunotherapeutics presented New Data at American Association for Cancer Reasearch annual meeting

OSE Immunotherapeutics Presented New Data at AACR* Annual Meeting 2017 on OSE-172 (Effi-DEM), Company’s Checkpoint Inhibitor Blocking Suppressive Myeloid Cells... View Article

Bioeurope Spring: positive balance for Atlanpole Biotherapies members

BioEurope Spring took place from 20 to 22 March in Barcelona. It is the first partnering conference between the pharmaceutical... View Article

Rédigé par Adeline Chauvigné, le 2017-04-07

Bioeurope Spring: positive balance for Atlanpole Biotherapies members

BioEurope Spring took place from 20 to 22 March in Barcelona. It is the first partnering conference between the pharmaceutical... View Article

CESTI-IHU: Dendritic cells and IL-22BP: targets for an innovative immunotherapeutic strategy

Dendritic cells and IL-22BP: targets for an innovative immunotherapeutic strategy for the treatment of inflammatory diseases Within the 1064 INSERM... View Article

Rédigé par Adeline Chauvigné, le 2017-04-07

CESTI-IHU: Dendritic cells and IL-22BP: targets for an innovative immunotherapeutic strategy

Dendritic cells and IL-22BP: targets for an innovative immunotherapeutic strategy for the treatment of inflammatory diseases Within the 1064 INSERM... View Article

International master’s degree in Microalgae Bioprocess Engineering in September 2017 (University of Nantes)

Openning in september 2017 ! In September 2017, Nantes University will launch a Master degree in Microalgae Bioprocess Engineering. This Master degree... View Article

Rédigé par Adeline Chauvigné, le 2017-04-07

International master’s degree in Microalgae Bioprocess Engineering in September 2017 (University of Nantes)

Openning in september 2017 ! In September 2017, Nantes University will launch a Master degree in Microalgae Bioprocess Engineering. This Master degree... View Article

Hemarina announces a fundraising of more than 8M€

Hemarina, the marine Biotechnology company centered on the development of innovative oxygen carriers, announces a fundraising of more than 8M€.... View Article

Rédigé par Adeline Chauvigné, le 2017-04-07

Hemarina announces a fundraising of more than 8M€

Hemarina, the marine Biotechnology company centered on the development of innovative oxygen carriers, announces a fundraising of more than 8M€.... View Article